169 related articles for article (PubMed ID: 35986452)
1. Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis.
Nobeyama Y; Umezawa Y; Asahina A
J Dermatol; 2022 Nov; 49(11):1168-1172. PubMed ID: 35986452
[TBL] [Abstract][Full Text] [Related]
2. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
3. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
[TBL] [Abstract][Full Text] [Related]
6. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
7. Genomic Progression of Precancerous Actinic Keratosis to Squamous Cell Carcinoma.
Kim YS; Shin S; Jung SH; Park YM; Park GS; Lee SH; Chung YJ
J Invest Dermatol; 2022 Mar; 142(3 Pt A):528-538.e8. PubMed ID: 34480890
[TBL] [Abstract][Full Text] [Related]
8. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
9. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.
Zalaudek I; Giacomel J; Schmid K; Bondino S; Rosendahl C; Cavicchini S; Tourlaki A; Gasparini S; Bourne P; Keir J; Kittler H; Eibenschutz L; Catricalà C; Argenziano G
J Am Acad Dermatol; 2012 Apr; 66(4):589-97. PubMed ID: 21839538
[TBL] [Abstract][Full Text] [Related]
10. Contemporary management of actinic keratosis.
Navarrete-Dechent C; Marghoob AA; Marchetti MA
J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
[TBL] [Abstract][Full Text] [Related]
11. Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study.
Jiyad Z; O'Rourke P; Soyer HP; Green AC
Br J Dermatol; 2017 Apr; 176(4):965-970. PubMed ID: 27584866
[TBL] [Abstract][Full Text] [Related]
12. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
13. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
[TBL] [Abstract][Full Text] [Related]
14. The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review.
Nguyen KP; Peppelman M; Hoogedoorn L; Van Erp PE; Gerritsen MP
Eur J Dermatol; 2016 Dec; 26(6):549-565. PubMed ID: 28007674
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.
Bromfield JI; Zaugg J; Straw RC; Cathie J; Krueger A; Sinha D; Chandra J; Hugenholtz P; Frazer IH
mSphere; 2024 Apr; 9(4):e0055523. PubMed ID: 38530017
[TBL] [Abstract][Full Text] [Related]
16. Non-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma.
Majidian M; Anderson J; Rock J; Ai R; Whitaker J; Howell M; Moy R
J Drugs Dermatol; 2023 May; 22(5):440-444. PubMed ID: 37133468
[TBL] [Abstract][Full Text] [Related]
17. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma.
Mittelbronn MA; Mullins DL; Ramos-Caro FA; Flowers FP
Int J Dermatol; 1998 Sep; 37(9):677-81. PubMed ID: 9762818
[TBL] [Abstract][Full Text] [Related]
18. Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma.
Inan Yuksel E; Cicek D; Demir B; Kocaman N; Calik I; Kuloglu T
Biotech Histochem; 2024 Feb; 99(2):61-68. PubMed ID: 38192243
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of actinic changes preceding squamous cell carcinoma vs. intraepidermal carcinoma in renal transplant recipients.
Jiyad Z; O'Rourke P; Soyer HP; Green AC
Clin Exp Dermatol; 2017 Dec; 42(8):895-897. PubMed ID: 28925042
[TBL] [Abstract][Full Text] [Related]
20. Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis.
Giuffrè G; Barresi V; Catalano A; Cappiello A; Stagno d'Alcontres F; Tuccari G
Eur J Histochem; 2008; 52(1):53-60. PubMed ID: 18502723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
